Novo Nordisk | Eigenkapital Und Reserven

Equity Capital And Reserves Veränderung Datum
ANI Pharmaceuticals USD 476.81M 19.21M 2024-03
Aurora Cannabis CAD 516.45M 12.67M 2023-12
Bausch Health Companies USD -174000000 848M 2024-03
Bristol-Myers Squibb USD 16.55B 12.45B 2024-03
Canopy Growth CAD 500.51M 44.02M 2024-03
Catalent USD 3.61B 76M 2024-03
Corcept Therapeutics USD 547.86M 41.16M 2024-03
Drreddys Laboratories INR 267.85B 14.76B 2023-12
Eli Lilly USD 12.9B 1.68B 2024-03
GlaxoSmithKline GBP 13.23B 118M 2024-03
Merck USD 40.42B 822M 2024-03
Novartis USD 39.76B 6.91B 2024-03
Novo Nordisk DKK 98.91B 7.65B 2024-03
Pacira USD 892.16M 22.03M 2024-03
Perrigo USD 4.69B 80.9M 2024-03
Prestige Brands USD 1.66B 54.51M 2024-03
Supernus Pharmaceuticals USD 929.17M 7.65M 2024-03
Zoetis USD 5.05B 55M 2024-03



Novo Nordisk Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jun 2024.